Gateway 2011: Hospira One 2 One - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Hospira One 2 One



Your online Gateway to Hospira One 2 One in 2011

275 North Field Drive
Lake Forest, Illinois, U.S.A. 60045
Call +1-224-212-2267



Don't miss Hospira One 2 One at BIO 2011, June 27-30, Washington, D.C.

About Hospira One 2 One

Hospira is a global specialty pharmaceutical and medication delivery company dedicated to developing, manufacturing and marketing healthcare products that help improve the productivity, safety and efficacy of patient care. The company’s One 2 One business is a world leader in the custom development and manufacture of sterile injectable products packaged in vials, prefilled syringes, cartridges, flexible containers and ampules.

We offer product development and contract manufacturing services at our nine worldwide facilities. Whether your product is a small molecule or advanced biologic, our highly qualified personnel in every world-class facility ensure quality, capacity and security of supply.

Visit our Stand: 4640

We would like to invite you to meet us at stand 4640 to discuss partnering and business development opportunities. 

 

For more information:

one2one@hospira.com

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here